MET
MetLife, Inc. NYSE$80.23
After hrs
$79.06
+0.14%
Mkt Cap $53.3B
52w Low $67.33
78.1% of range
52w High $83.85
50d MA $73.29
200d MA $77.34
P/E (TTM)
16.7x
EV/EBITDA
8.9x
P/B
1.8x
Debt/Equity
0.7x
ROE
11.9%
P/FCF
2.9x
RSI (14)
—
ATR (14)
—
Beta
0.73
50d MA
$73.29
200d MA
$77.34
Avg Volume
4.0M
About
MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment,…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | 1M% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 4, 2026 | AMC | 2.34 | 2.58 | +10.3% | 78.01 | +1.9% | -3.4% | -2.1% | -2.2% | -0.1% | +1.1% | -7.9% | — |
| Nov 5, 2025 | AMC | 2.31 | 2.34 | +1.3% | 78.68 | +1.0% | -3.4% | -3.2% | -1.9% | -1.1% | +1.9% | -0.0% | — |
| Aug 6, 2025 | AMC | 2.15 | 2.02 | -6.0% | 75.95 | -5.1% | -2.8% | +0.4% | -0.9% | +0.8% | +1.9% | +4.7% | — |
| Apr 30, 2025 | AMC | 2.00 | 1.96 | -2.0% | 75.37 | +1.3% | +0.5% | +3.2% | +2.7% | +1.4% | +1.8% | +4.3% | — |
| Feb 5, 2025 | AMC | 2.11 | 2.08 | -1.4% | 85.00 | -2.0% | -1.6% | -1.3% | -2.3% | -2.2% | -2.7% | -3.2% | — |
| Oct 30, 2024 | AMC | 2.17 | 1.95 | -10.1% | 83.18 | -7.9% | -5.7% | -5.7% | -5.6% | -6.0% | +0.1% | +6.1% | — |
| Jul 31, 2024 | AMC | 2.10 | 2.28 | +8.6% | 76.85 | +2.3% | -1.4% | -8.2% | -11.6% | -10.7% | -10.6% | +0.8% | — |
| May 1, 2024 | AMC | 1.84 | 1.83 | -0.5% | 71.88 | +0.7% | -2.3% | -1.9% | -1.0% | -0.9% | -0.3% | +0.7% | — |
| Jan 31, 2024 | AMC | 1.88 | 1.93 | +2.7% | 69.32 | -4.6% | -5.7% | -4.9% | -5.1% | -4.8% | -3.3% | +0.6% | — |
| Nov 1, 2023 | AMC | 1.99 | 1.97 | -1.0% | 59.98 | +0.0% | +0.1% | +3.0% | +0.8% | +0.1% | -1.1% | +6.3% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 14 | BofA Securities | Maintains | Buy → Buy | — | $75.36 | $75.41 | +0.1% | +0.9% | +2.9% | +2.3% | +3.6% | +3.1% |
| Apr 13 | Mizuho | Maintains | Outperform → Outperform | — | $73.88 | $73.22 | -0.9% | +2.0% | +2.9% | +4.9% | +4.3% | +5.7% |
| Apr 10 | Wells Fargo | Maintains | Overweight → Overweight | — | $74.65 | $74.61 | -0.1% | -1.0% | +1.0% | +1.9% | +3.8% | +3.3% |
| Apr 9 | UBS | Maintains | Buy → Buy | — | $74.34 | $73.78 | -0.8% | +0.4% | -0.6% | +1.4% | +2.3% | +4.3% |
| Apr 9 | Evercore ISI | Maintains | In Line → In Line | — | $74.34 | $73.78 | -0.8% | +0.4% | -0.6% | +1.4% | +2.3% | +4.3% |
| Apr 8 | Barclays | Maintains | Overweight → Overweight | — | $71.20 | $73.20 | +2.8% | +4.4% | +4.8% | +3.8% | +5.8% | +6.8% |
| Mar 11 | TD Cowen | Maintains | Buy → Buy | — | $70.60 | $70.73 | +0.2% | -0.9% | -2.6% | -3.7% | -2.0% | -1.8% |
| Mar 3 | Morgan Stanley | Maintains | Overweight → Overweight | — | $73.24 | $71.98 | -1.7% | -0.8% | +0.1% | -0.4% | -1.9% | -3.4% |
| Feb 25 | Wells Fargo | Maintains | Overweight → Overweight | — | $75.34 | $75.80 | +0.6% | -0.0% | +0.8% | -4.3% | -2.8% | -3.5% |
| Feb 11 | Evercore ISI | Maintains | In Line → In Line | — | $77.92 | $77.95 | +0.0% | +1.2% | -0.7% | -0.8% | +0.8% | +1.7% |
Recent Filings
8-K
MetLife, Inc. -- 8-K Filing
MetLife confirmed its Q1 2026 dividend of $0.315 per share on its Series A preferred stock, maintaining consistent distributions to preferred shareholders.
Mar 5
8-K
MetLife, Inc. -- 8-K Filing
MetLife priced a debenture offering underwritten by major banks including Barclays, BofA Securities, Citigroup, Goldman Sachs, and Wells Fargo to raise capital through debt financing.
Feb 26
8-K
MetLife, Inc. -- 8-K Filing
I appreciate your submission, but I cannot provide analysis of this filing. The summary provided doesn't contain substantive information about a specific corporate event or transaction—it only describes filing classification mechanics. Please provide a summary with details about actual business developments.
Feb 24
8-K
MetLife, Inc. -- 8-K Filing
MetLife declared quarterly dividends on three preferred stock series (5.625% Series E, 4.75% Series F, and floating rate Series A), with Series A dividend subject to financial test confirmation.
Feb 17
8-K · 8.01
!! High
MetLife, Inc. -- 8-K 8.01: Material Event / Announcement
MetLife furnished earnings presentation materials to investors without filing them formally, indicating the company held an earnings call to discuss financial results and asset management metrics.
Feb 4
Data updated apr 26, 2026 11:54am
· Source: massive.com